Literature DB >> 22882291

Clinical manifestations and treatment for keratocystic odontogenic tumors associated with nevoid basal cell carcinoma syndrome: a study in 25 Japanese patients.

Yasuyuki Shimada1, Kei-ichi Morita, Yuji Kabasawa, Takahide Taguchi, Ken Omura.   

Abstract

BACKGROUND: Nevoid basal cell carcinoma syndrome (NBCCS) is an autosomal dominant disorder and is characterized by tumorigenesis and physical deformity. Keratocystic odontogenic tumors (KCOTs) of the jaws are a common manifestation of this syndrome. This study involved a pooled analysis of Japanese individuals with NBCCS and was performed with the aim of analyzing the clinical features of NBCCS and the patterns of occurrence and recurrence of KCOTs in Japanese individuals.
METHODS: This study included 25 patients. The relative frequencies of the major symptoms in these patients were compared with those reported in the literature. We also investigated 11 patients with KCOTs (40 lesions) initially treated at Tokyo Medical and Dental University.
RESULTS: KCOTs (100%) and palmar and/or plantar pits (n = 19; 76.0%) were the most frequently observed manifestations. Eleven patients (44.0%) had a radiologically confirmed rib anomaly. Nineteen patients (76.0%) had a family history of the syndrome within first-degree relatives. Japanese patients had a relatively low frequency of basal cell carcinoma (n = 7; 28.0%) and falx calcification (n = 7; 28.0%) compared with that reported in other populations. Twelve of the total 40 KCOTs (30.0%) that were followed up for 6 months or more recurred. All recurrent cases had undergone conservative treatment, whereas no recurrences occurred in cases that had undergone radical treatment.
CONCLUSIONS: Recurrence of KCOTs associated with NBCCS is frequently encountered, and further investigations are required to confirm the optimal treatment that will ensure a complete cure improving the patient's quality of life.
© 2012 John Wiley & Sons A/S. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22882291     DOI: 10.1111/j.1600-0714.2012.01202.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  7 in total

1.  Conservative treatment protocol of keratocystic odontogenic tumor: report of a case with nevoid Basal cell carcinoma syndrome and literature review.

Authors:  Dariush Hasheminia; Vahid Naemi; Navid Naghdi
Journal:  J Maxillofac Oral Surg       Date:  2014-09-14

2.  Synchronous occurrence of two lateral periodontal cysts in the same patient. Report of a rare case and review of the literature.

Authors:  Ilias Karveleas; Eleni-Marina Kalogirou; Konstantinos I Tosios; Nikolaos G Nikitakis
Journal:  J Clin Exp Dent       Date:  2020-04-01

3.  Non-Syndromic Familial Keratocystic Odontogenic Tumour: A Rare Case Report in Japanese Identical Twins.

Authors:  Yasuyuki Shimada; Yutaka Maruoka; Iena Yamaji; Shigeo Kawai
Journal:  J Clin Diagn Res       Date:  2016-08-01

4.  Integrated genotypic analysis of hedgehog-related genes identifies subgroups of keratocystic odontogenic tumor with distinct clinicopathological features.

Authors:  Yasuyuki Shimada; Ken-ichi Katsube; Yuji Kabasawa; Kei-ichi Morita; Ken Omura; Akira Yamaguchi; Kei Sakamoto
Journal:  PLoS One       Date:  2013-08-07       Impact factor: 3.240

5.  Nevoid Basal Cell Carcinoma Syndrome: A Case Report and Review of Korean Cases.

Authors:  Eun-Joo Jung; Hyokeun Shin; Jin-A Baek; Dae-Ho Leem; Seung-O Ko
Journal:  Maxillofac Plast Reconstr Surg       Date:  2014-11-12

6.  Multidisciplinary oral rehabilitation of an adolescent suffering from juvenile Gorlin-Goltz syndrome - a case report.

Authors:  Manfred Nilius; Jürgen Kohlhase; Johann Lorenzen; Günter Lauer; Matthias C Schulz
Journal:  Head Face Med       Date:  2019-02-08       Impact factor: 2.151

7.  Simultaneous Detection of Both Single Nucleotide Variations and Copy Number Alterations by Next-Generation Sequencing in Gorlin Syndrome.

Authors:  Kei-ichi Morita; Takuya Naruto; Kousuke Tanimoto; Chisato Yasukawa; Yu Oikawa; Kiyoshi Masuda; Issei Imoto; Johji Inazawa; Ken Omura; Hiroyuki Harada
Journal:  PLoS One       Date:  2015-11-06       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.